Autoimmune acquired form of angioedema that responded to danazol therapy

Internal Medicine

Volumn 41, Issue 5, 2002, Pages 398-402

  Higa, Shinji ^a   Hirata, Haruhiko ^a   Minami, Seigou ^b   Hashimoto, Shouji ^c   Suemura, Masaki ^d   Saeki, Yukihiko ^a   Kawase, Ichiro ^a   Tanaka, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c TONEYAMA NATIONAL HOSPITAL   (Japan)

^d Nissay Hospital   (Japan)

Author keywords

Acquired angioedema; Autoantibody; C1 INH

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C1S INHIBITOR ANTIBODY; COMPLEMENT COMPONENT C4; DANAZOL; UNCLASSIFIED DRUG; ANTIESTROGEN;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; COMPLEMENT HEMOLYSIS TEST; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG RESPONSE; FAMILY HISTORY; HUMAN; JAPAN; MALE; ONSET AGE; RECURRENT DISEASE; SIDE EFFECT; BLOOD; IMMUNOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ANGIONEUROTIC EDEMA; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COMPLEMENT C1 INACTIVATOR PROTEINS; DANAZOL; ESTROGEN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0036019084     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.398     Document Type: Article

References (31)

1. Urticaria and Angioedema
2. Acquired C1 esterase inhibitor deficiency
3. Hereditary and acquired C1-inhibitor deficiency: Biological and clinical characteristics in 235 patients
4. C1 inhibitor and hereditary angioneurotic edema
5. C-1-inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema
6. Acquired C1-inhibitor deficiency
7. Activation of complement by a monoclonal cryoglobulin associated with cold urticaria
8. Angioedema and multiple myeloma. I
9. Acquired C1-inhibitor deficiency in essential cryoglobulinemia and macrocryoglobulinemia
10. Acquired deficiency in C1-inhibitor associated with signet ring cell gastric adenocarcinoma: A probable connection of antitumor-associated antibodies, hemolytic anemia, and complement turnover
11. Acquired C1 inhibitor deficiency in lymphosarcoma
12. An IgG autoantibody which inactivates C1-inhibitor
13. Autoantibody-mediated acquired deficiency of C1 inhibitor
14. Acquired angioedema type II (AAE-II): A new auto-immune disease
15. The acquired C1-INH deficiencies with autoantibodies (AAE type II)
16. Acquired angioedema and anti-C1-inhibitor autoantibody
17. Acquired angioedema: Observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor
18. Human C1 inhibitor; improved isolation and preliminary structural characterization
19. Molecular genetics of C1 inhibitor
20. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema
21. Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor
22. Mechanism of action of anti-C1-inhibitor autoantibodies: Prevention of the formation of stable C1s-C1-inh complexes
23. Autoimmune C1-inhibitor deficiency
24. Pathogenetic and clinical aspects of C1 inhibitor deficiency
25. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor
26. Acquired angioneurotic edema. Clinical and biological characteristics in 9 patients
27. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies
28. Autoimmune C1 inhibitor deficiency: Report of eight patients
29. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system
30. Acute occlusion of blood access in the patients with C1-inhibitor deficiency undergoing hemodialysis therapy
31. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities